As part of the agreement, BioClinica becomes ArisGlobal's preferred partner in business process consulting and change management as sponsors implement or upgrade ARISg, ArisGlobal's pharmacovigilance and clinical safety system. The cloud-based solution helps facilitate drug development and regulatory compliance throughout the entire product life cycle. "We decided to partner with ArisGlobal because we saw the opportunity to offer a continuum of pharmacovigilance services that can fit the needs of sponsors and CROs as those needs change, whether sponsors are growing, merging, experiencing a surge or a drop in safety events," Mukhtar Ahmed, BioClinica President eHealth Solutions, told Outsourcing-Pharma.com. "In the same way that therapies are moving from a'one size fits all' model, so is our offering model." According to the company, the partners are currently working to develop ArisGlobal's next generation of products, which will combine medical knowledge with technologies derived from such areas as artificial intelligence, machine learning, and natural language processing.